New B&L manager in Ireland

Article

Colum Honan is to be Bausch & Lomb's general manager with responsibility for its Waterford plant which manufactures contact lenses and other eye health products.

Colum Honan is to be Bausch & Lomb's general manager with responsibility for its Waterford plant which manufactures contact lenses and other eye health products.

He was previously deputy general manager and held a number of positions in which he managed successful projects where new products were taken from design to manufacturing to market launch.

Honan was involved with the successful transfer of the key new PureVision lens from the research and development stage to manufacturing.

In 1999, he was given responsibility as site leader for the industrialization of a new drug application which is now marketed as Retisert, a fluocinolone acetonide intravitreal implant, which represents a dramatic advance in the management of chronic non-infectious uveitis affecting the posterior segment of the eye.

He replaces Frank O'Regan, who last year was named vice president, Operations, Global Vision Care. Honan continues to report to O'Regan.

Welcoming the appointment, Frank O'Regan said: "Colum has a solid record of taking new products and processes from early product development phases right through to successful market launch with maximum efficiency. He takes over responsibility for the Waterford manufacturing site at a very challenging time when his management strengths will be a major asset in steering the business to a successful future."

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.